Shorter (≤6 months) versus longer (≥12 months) duration dual antiplatelet therapy after drug eluting stents: a meta-analysis of randomized clinical trials.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Optimal duration of dual antiplatelet therapy (DAPT), defined as use of both aspirin and a P2Y12 receptor inhibitor, after implantation of drug eluting stents (DES) is still subject of ongoing debate. We systematically review efficacy and safety of ≤6 months versus ≥12 months DAPT after implantation of DES.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Catheter Cardiovasc Interv

Title: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions

ISSN (Electronic): 1522-726X

ISSN (Print): 1522-1946

Publication date (Electronic): Jan 1 2015

Volume: 85

Issue: 1

Affiliations

[1 ] Division of Cardiovascular Diseases, Mayo Clinic, Scottsdale, Arizona.

Article

DOI: 10.1002/ccd.25520

PubMed ID: 24753084

SO-VID: 2a3ebfb2-9417-48eb-a2ee-69971d3e1e3c

History

Keywords: antiplatelet therapy,coronary artery disease,drug eluting stent

Data availability:

Keywords: antiplatelet therapy, coronary artery disease, drug eluting stent

Comments

Comment on this article

scite_

Smart Citations

Citing PublicationsSupportingMentioningContrasting

View Citations

See how this article has been cited at scite.ai

scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

Cited by 12

See all cited by